While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.

FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes

By BioPharm International Editors

September 23rd 2019

FDA has approved Novo Nordisk’s Rybelsus (semaglutide), a glucagon-like peptide receptor protein treatment in oral tablet form for type 2 diabetes.

Nanoform Invests in Nanoparticle Technology for Drug Development

By BioPharm International Editors

September 19th 2018

The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.

Sensor Technology Aims to Improve Medication Adherence

By BioPharm International Editors

March 16th 2018

Sensors and devices being developed by nGageIT Digital Health Solutions can track patient use of oral solid-dosage or injectable drugs.

Formulation of Biologics for Non-Invasive Delivery

By Adeline Siew, PhD

October 1st 2017

There is a lot of interest in delivering biologics via non-invasive routes in attempt to improve patient compliance and convenience.

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777